Table of Contents
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
3 Definitions of the March kets Covered in the Report 13
3.1 Patient Monitoring 13
3.2 Micro-Electromechanical Systems 13
3.3 Multiparameter Patient Monitoring 13
3.3.1 Critical Care Monitors 13
3.3.2 Perioperative Care Monitors 13
3.4 Non-Invasive Blood Pressure Monitors 13
3.4.1 Aneroid Sphygmomanometer 13
3.4.2 Automatic Sphygmomanometer 14
3.4.3 Mercury Sphygmomanometer 14
3.5 Remote Patient Monitoring 14
3.6 Wireless and Ambulatory Monitoring 14
3.6.1 Cardiac Rehabilitation Ambulatory 14
3.6.2 Hospital Ambulatory 14
4 Healthcare Segment Review 15
4.1 Healthcare Segment Review 15
4.2 Healthcare Expenditure 15
5 Regulation System 16
5.1 Regulatory System 16
5.2 Registration 16
5.3 Standards 17
5.4 Customs Duties 17
5.5 Labeling 17
6 Pricing and Reimbursement 18
7 Distribution Structure 19
8 Patient Monitoring In Israel 20
8.1 Patient Monitoring Cross Country Comparison, Revenue ($ mn), from 2000 to 2015 20
8.2 Patient Monitoring, Israel, Overall Revenue ($ mn), from 2000 to 2015 21
8.3 Patient Monitoring, Israel, Category Volume (Units), from 2000 to 2015 27
8.4 Patient Monitoring, Israel, Firms Share (2006-2007) 29
9 Micro-Electromechanical Systems In Israel 30
9.1 Micro-Electromechanical Systems Overall Revenue (from 2000 to 2015 ) 30
9.2 Micro-Electromechanical Systems Overall Volume (from 2000 to 2015 ) 32
9.3 Micro-Electromechanical Systems Average Price (from 2000 to 2015 ) 34
9.4 Micro-Electromechanical Systems Distribution Share (2007-2008) 35
9.5 Micro-Electromechanical Systems, Israel, Firms Share (2006-2007) 36
10 Multiparameter Patient Monitoring In Israel 37
10.1 Multiparameter Patient Monitoring Overall Revenue (from 2000 to 2015 ) 37
10.2 Multiparameter Patient Monitoring Overall Volume (from 2000 to 2015 ) 39
10.3 Multiparameter Patient Monitoring Average Price (from 2000 to 2015 ) 41
10.4 Multiparameter Patient Monitoring Distribution Share (2007-2008) 42
10.5 Multiparameter Patient Monitoring, Israel, Firms Share (2006-2007) 43
11 Non-Invasive Blood Pressure Monitors In Israel 44
11.1 Non-Invasive Blood Pressure Monitors Overall Revenue (from 2000 to 2015 ) 44
11.2 Non-Invasive Blood Pressure Monitors Overall Volume (from 2000 to 2015 ) 46
11.3 Non-Invasive Blood Pressure Monitors Average Price (from 2000 to 2015 ) 48
11.4 Non-Invasive Blood Pressure Monitors Distribution Share (2007-2008) 49
11.5 Non-Invasive Blood Pressure Monitors, Israel, Firms Share (2006-2007) 50
12 Remote Patient Monitoring In Israel 51
12.1 Remote Patient Monitoring Overall Revenue (from 2000 to 2015 ) 51
12.2 Remote Patient Monitoring Overall Volume (from 2000 to 2015 ) 53
12.3 Remote Patient Monitoring Average Price (from 2000 to 2015 ) 55
12.4 Remote Patient Monitoring Distribution Share (2007-2008) 56
12.5 Remote Patient Monitoring, Israel, Firms Share (2006-2007) 57
13 Wireless and Ambulatory Monitoring In Israel 58
13.1 Wireless and Ambulatory Monitoring Overall Revenue (from 2000 to 2015 ) 58
13.2 Wireless and Ambulatory Monitoring Overall Volume (from 2000 to 2015 ) 60
13.3 Wireless and Ambulatory Monitoring Average Price (from 2000 to 2015 ) 62
13.4 Wireless and Ambulatory Monitoring Distribution Share (2007-2008) 63
13.5 Wireless and Ambulatory Monitoring, Israel, Firms Share (2006-2007) 64
14 Overview of Key Firms in Israel Patient Monitoring March ket 65
14.1 GE Healthcare 65
14.1.1 Corporate Presentation 65
14.2 Draegerwerk AG & Co. KGaA 66
14.2.1 Corporate Presentation 66
14.2.2 Value Chain Analysis 66
14.2.2.1 Manufacturing 67
14.2.2.2 Product Development 67
14.2.2.3 Sales and March keting 67
14.2.3 Drager Medical AG & Co. KG Pipeline Products 68
14.2.3.1 Drager Medical AG & Co. KG Pipeline Products By Equipment Type 68
14.2.3.2 Drager Medical AG & Co. KG Pipeline Products By Development Stage 68
14.2.3.3 Drager Medical AG & Co. KG Pipeline Products By Therapy Area 68
14.3 Philips Healthcare 69
14.3.1 Corporate Presentation 69
14.3.2 Value Chain Analysis 70
14.3.2.1 Manufacturing 70
14.3.2.2 Product Development 71
14.3.2.3 Sales and March keting 71
14.4 Abbott Laboratories 73
14.4.1 Corporate Presentation 73
14.4.2 Value Chain Analysis 74
14.4.2.1 Manufacturing 74
14.4.2.2 Product Development 74
14.4.2.3 Sales and March keting 76
14.5 OMRON HEALTHCARE Co., Ltd. 77
14.5.1 Corporate Presentation 77
14.5.2 OMRON HEALTHCARE Co., Ltd. Pipeline Products 77
14.5.2.1 OMRON HEALTHCARE Co., Ltd. Pipeline Products By Equipment Type 77
14.5.2.2 OMRON HEALTHCARE Co., Ltd. Pipeline Products By Development Stage 77
14.5.2.3 OMRON HEALTHCARE Co., Ltd. Pipeline Products By Therapy Area 78
14.5.2.4 OMRON HEALTHCARE Co., Ltd. Pipeline Products By News Summary 78
14.6 Datascope Corporation 79
14.6.1 Corporate Presentation 79
14.6.2 Value Chain Analysis 79
14.6.2.1 Manufacturing 80
14.6.2.2 Product Development 80
14.6.2.3 Sales and March keting 81
14.7 OSI Systems, Inc. 82
14.7.1 Corporate Presentation 82
14.7.2 Value Chain Analysis 82
14.7.2.1 Manufacturing 83
14.7.2.2 Product Development 83
14.7.2.3 Sales and March keting 83
14.8 HARTMANN GROUP 84
14.8.1 Corporate Presentation 84
14.8.2 Value Chain Analysis 84
14.8.2.1 Manufacturing 85
14.8.2.2 Product Development 85
14.8.2.3 Sales and March keting 85
14.9 Nihon Kohden Corporation 86
14.9.1 Corporate Presentation 86
14.9.2 Value Chain Analysis 87
14.9.2.1 Manufacturing 87
14.9.2.2 Product Development 87
14.9.2.3 Sales and March keting 88
14.10 Medtronic, Inc. 89
14.10.1 Corporate Presentation 89
14.10.2 Value Chain Analysis 89
14.10.2.1 Manufacturing 89
14.10.2.2 Product Development 90
14.10.2.3 Sales and March keting 90
14.11 Boston Scientific Corporation 92
14.11.1 Corporate Presentation 92
14.11.2 Value Chain Analysis 92
14.11.2.1 Manufacturing 93
14.11.2.2 Product Development 93
14.11.2.3 Sales and March keting 94
14.12 St. Jude Medical Inc. 95
14.12.1 Corporate Presentation 95
14.12.2 Value Chain Analysis 95
14.12.2.1 Manufacturing 96
14.12.2.2 Product Development 96
14.12.2.3 Sales and March keting 97
14.13 Edwards Lifesciences Corporation 98
14.13.1 Corporate Presentation 98
14.13.2 Value Chain Analysis 98
14.13.2.1 Manufacturing 99
14.13.2.2 Product Development 99
14.13.2.3 Sales and March keting 100
14.14 BIOTRONIK GmbH & Co. KG 101
14.14.1 Corporate Presentation 101
14.15 Mennen Medical Ltd. 101
14.15.1 Corporate Presentation 101
14.16 Panasonic Corporation 102
14.16.1 Corporate Presentation 102
14.17 GE Sensing 102
14.17.1 Corporate Presentation 102
14.18 Braun GmbH 102
14.18.1 Corporate Presentation 102
14.19 Barnev Inc. 103
14.19.1 Corporate Presentation 103
14.20 Home Free Systems LTD. 103
14.20.1 Corporate Presentation 103
14.21 Oridion Systems Ltd. 103
14.21.1 Corporate Presentation 103
15 Appendix 104
15.1 Global March kets Direct Research Methodology 104
15.2 Coverage 105
15.3 Secondary Research 105
15.4 Primary Research 106
15.5 Models 106
15.6 Projections 107
15.7 Expert Panel Validation 107
15.8 Currency Conversion 108
15.9 Contact Us 109
15.10 Disclaimer 109
List of Tables
Table 1: Patient Monitoring, Cross Country Comparison, Revenue ($ mn), from 2000 to 2015 20
Table 2: Patient Monitoring, Israel, Overall Revenue ($ mn), from 2000 to 2015 21
Table 3: Patient Monitoring, Israel, Cross-Category Analysis, from 2000 to 2015 22
Table 4: Patient Monitoring, Israel, Overall Revenue ($ mn), Historic, from 2000 to 2008 24
Table 5: Patient Monitoring, Israel, Overall Revenue ($ mn), Projection , from 2008 to 2015 26
Table 6: Patient Monitoring, Israel, Category Volume (Units), from 2000 to 2015 27
Table 7: Patient Monitoring, Israel, Category Volume (Units), Historic, from 2000 to 2008 27
Table 8: Patient Monitoring, Israel, Category Volume (Units), Projection , from 2008 to 2015 28
Table 9: Patient Monitoring, Israel Firms Share by Revenue ($ mn), from 2006 to 2007 29
Table 10: Micro-Electromechanical Systems, Israel, Revenue ($ mn), Historic, from 2000 to 2008 30
Table 11: Micro-Electromechanical Systems, Israel, Revenue ($ mn), Projection , from 2008 to 2015 31
Table 12: Micro-Electromechanical Systems, Israel, Volume (Units), Historic, from 2000 to 2008 32
Table 13: Micro-Electromechanical Systems, Israel, Volume (Units), Projection , from 2008 to 2015 33
Table 14: Micro-Electromechanical Systems, Israel, Average Price ($), Historic, from 2000 to 2008 34
Table 15: Micro-Electromechanical Systems, Israel, Average Price ($), Projection , from 2008 to 2015 34
Table 16: Micro-Electromechanical Systems, Israel, Distribution Share by Revenue ($mn), from 2007 to 2008 35
Table 17: Micro-Electromechanical Systems, Israel, Firms Share by Revenue ($ mn), from 2006 to 2007 36
Table 18: Multiparameter Patient Monitoring, Israel, Revenue ($ mn) by Segment, Historic, from 2000 to 2008 37
Table 19: Multiparameter Patient Monitoring, Israel, Revenue ($ mn) by Segment, Projection , from 2008 to 2015 38
Table 20: Multiparameter Patient Monitoring, Israel, Volume (Units) by Segment, Historic, from 2000 to 2008 39
Table 21: Multiparameter Patient Monitoring, Israel, Volume (Units) by Segment, Projection , from 2008 to 2015 40
Table 22: Multiparameter Patient Monitoring, Israel, Average Price ($), Historic, from 2000 to 2008 41
Table 23: Multiparameter Patient Monitoring, Israel, Average Price ($), Projection , from 2008 to 2015 41
Table 24: Multiparameter Patient Monitoring, Israel, Distribution Share by Revenue ($mn), from 2007 to 2008 42
Table 25: Multiparameter Patient Monitoring, Israel, Firms Share by Revenue ($ mn), from 2006 to 2007 43
Table 26: Non-Invasive Blood Pressure Monitors, Israel, Revenue ($ mn) by Segment, Historic, from 2000 to 2008 44
Table 27: Non-Invasive Blood Pressure Monitors, Israel, Revenue ($ mn) by Segment, Projection , from 2008 to 2015 45
Table 28: Non-Invasive Blood Pressure Monitors, Israel, Volume (Units) by Segment, Historic, from 2000 to 2008 46
Table 29: Non-Invasive Blood Pressure Monitors, Israel, Volume (Units) by Segment, Projection , from 2008 to 2015 47
Table 30: Non-Invasive Blood Pressure Monitors, Israel, Average Price ($), Historic, from 2000 to 2008 48
Table 31: Non-Invasive Blood Pressure Monitors, Israel, Average Price ($), Projection , from 2008 to 2015 48
Table 32: Non-Invasive Blood Pressure Monitors, Israel, Distribution Share by Revenue ($mn), from 2007 to 2008 49
Table 33: Non-Invasive Blood Pressure Monitors, Israel, Firms Share by Revenue ($ mn), from 2006 to 2007 50
Table 34: Remote Patient Monitoring, Israel, Revenue ($ mn), Historic, from 2000 to 2008 51
Table 35: Remote Patient Monitoring, Israel, Revenue ($ mn), Projection , from 2008 to 2015 52
Table 36: Remote Patient Monitoring, Israel, Volume (Units), Historic, from 2000 to 2008 53
Table 37: Remote Patient Monitoring, Israel, Volume (Units), Projection , from 2008 to 2015 54
Table 38: Remote Patient Monitoring, Israel, Average Price ($), Historic, from 2000 to 2008 55
Table 39: Remote Patient Monitoring, Israel, Average Price ($), Projection , from 2008 to 2015 55
Table 40: Remote Patient Monitoring, Israel, Distribution Share by Revenue ($mn), from 2007 to 2008 56
Table 41: Remote Patient Monitoring, Israel, Firms Share by Revenue ($ mn), from 2006 to 2007 57
Table 42: Wireless and Ambulatory Monitoring, Israel, Revenue ($ mn) by Segment, Historic, from 2000 to 2008 58
Table 43: Wireless and Ambulatory Monitoring, Israel, Revenue ($ mn) by Segment, Projection , from 2008 to 2015 59
Table 44: Wireless and Ambulatory Monitoring, Israel, Volume (Units) by Segment, Historic, from 2000 to 2008 60
Table 45: Wireless and Ambulatory Monitoring, Israel, Volume (Units) by Segment, Projection , from 2008 to 2015 61
Table 46: Wireless and Ambulatory Monitoring, Israel, Average Price ($), Historic, from 2000 to 2008 62
Table 47: Wireless and Ambulatory Monitoring, Israel, Average Price ($), Projection , from 2008 to 2015 62
Table 48: Wireless and Ambulatory Monitoring, Israel, Distribution Share by Revenue ($mn), from 2007 to 2008 63
Table 49: Wireless and Ambulatory Monitoring, Israel, Firms Share by Revenue ($ mn), from 2006 to 2007 64
Table 50: Drager Medical AG & Co. KG Pipeline Products by Equipment Type 68
Table 51: Drager Medical AG & Co. KG Pipeline Products By Development Stage 68
Table 52: Drager Medical AG & Co. KG Pipeline Products By Therapy Area 68
Table 53: OMRON HEALTHCARE Co., Ltd. Pipeline Products by Equipment Type 77
Table 54: OMRON HEALTHCARE Co., Ltd. Pipeline Products By Development Stage 77
Table 55: OMRON HEALTHCARE Co., Ltd. Pipeline Products By Therapy Area 78
Table 56: OMRON HEALTHCARE Co., Ltd. Pipeline Products By News Summary 78
Table 57: US Dollar to Local Currency, Average Exchange Rate 2008 108
List of Figures
Figure 1: Patient Monitoring, Cross Country Comparison, Revenue ($ mn), from 2000 to 2015 20
Figure 2: Patient Monitoring, Israel, Overall Revenue ($ mn), from 2000 to 2015 21
Figure 3: Patient Monitoring, Israel, Cross-Category Analysis, from 2000 to 2015 22
Figure 4: Patient Monitoring, Israel, Overall Revenue ($ mn), Historic, from 2000 to 2008 23
Figure 5: Patient Monitoring, Israel, Overall Revenue ($ mn), Projection , from 2008 to 2015 25
Figure 6: Patient Monitoring, Israel,Company Share (%), 2007 29
Figure 7: Micro-Electromechanical Systems, Israel, Revenue ($ mn), Historic, from 2000 to 2008 30
Figure 8: Micro-Electromechanical Systems, Israel, Revenue ($ mn), Projection , from 2008 to 2015 31
Figure 9: Micro-Electromechanical Systems, Israel, Volume (Units), Historic, from 2000 to 2008 32
Figure 10: Micro-Electromechanical Systems, Israel, Volume (Units), Projection , from 2008 to 2015 33
Figure 11: Micro-Electromechanical Systems, Israel, Firms Share (%), 2007 36
Figure 12: Multiparameter Patient Monitoring, Israel, Revenue ($ mn) by Segment, Historic, from 2000 to 2008 37
Figure 13: Multiparameter Patient Monitoring, Israel, Revenue ($ mn) by Segment, Projection , from 2008 to 2015 38
Figure 14: Multiparameter Patient Monitoring, Israel, Volume (Units) by Segment, Historic, from 2000 to 2008 39
Figure 15: Multiparameter Patient Monitoring, Israel, Volume (Units) by Segment, Projection , from 2008 to 2015 40
Figure 16: Multiparameter Patient Monitoring, Israel, Firms Share (%), 2007 43
Figure 17: Non-Invasive Blood Pressure Monitors, Israel, Revenue ($ mn) by Segment, Historic, from 2000 to 2008 44
Figure 18: Non-Invasive Blood Pressure Monitors, Israel, Revenue ($ mn) by Segment, Projection , from 2008 to 2015 45
Figure 19: Non-Invasive Blood Pressure Monitors, Israel, Volume (Units) by Segment, Historic, from 2000 to 2008 46
Figure 20: Non-Invasive Blood Pressure Monitors, Israel, Volume (Units) by Segment, Projection , from 2008 to 2015 47
Figure 21: Non-Invasive Blood Pressure Monitors, Israel, Firms Share (%), 2007 50
Figure 22: Remote Patient Monitoring, Israel, Revenue ($ mn), Historic, from 2000 to 2008 51
Figure 23: Remote Patient Monitoring, Israel, Revenue ($ mn), Projection , from 2008 to 2015 52
Figure 24: Remote Patient Monitoring, Israel, Volume (Units), Historic, from 2000 to 2008 53
Figure 25: Remote Patient Monitoring, Israel, Volume (Units), Projection , from 2008 to 2015 54
Figure 26: Remote Patient Monitoring, Israel, Firms Share (%), 2007 57
Figure 27: Wireless and Ambulatory Monitoring, Israel, Revenue ($ mn) by Segment, Historic, from 2000 to 2008 58
Figure 28: Wireless and Ambulatory Monitoring, Israel, Revenue ($ mn) by Segment, Projection , from 2008 to 2015 59
Figure 29: Wireless and Ambulatory Monitoring, Israel, Volume (Units) by Segment, Historic, from 2000 to 2008 60
Figure 30: Wireless and Ambulatory Monitoring, Israel, Volume (Units) by Segment, Projection , from 2008 to 2015 61
Figure 31: Wireless and Ambulatory Monitoring, Israel, Firms Share (%), 2007 64
Figure 32: Drager Medical AG & Co. KG Value Chain Analysis 66
Figure 33: Philips Medical Systems Value Chain Analysis 70
Figure 34: Abbott Laboratories Value Chain Analysis 74
Figure 35: Datascope Corp. Value Chain Analysis 79
Figure 36: OSI Systems, Inc. Value Chain Analysis 82
Figure 37: Hartmann Group Value Chain Analysis 84
Figure 38: Nihon Kohden Corporation Value Chain Analysis 87
Figure 39: Medtronic, Inc. Value Chain Analysis 89
Figure 40: Boston Scientific Corporation Value Chain Analysis 92
Figure 41: St. Jude Medical Inc. Value Chain Analysis 95
Figure 42: Edwards Lifesciences Corporation Value Chain Analysis 98
Figure 43: Global March kets Direct Methodology 104